Accepted Manuscript Liposomal formulation of hypoxia activated prodrug for the treatment of ovarian cancer Vidhi M. Shah, Duc X. Nguyen, Adel Al Fatease, Pragnesh Patel, Brianna Cote, Yeonhee Woo, Rohi Gheewala, Yvonne Pham, Man Gia Huynh, Christen Gannett, Deepa A. Rao, Adam W.G. Alani PII: S0168-3659(18)30592-3 DOI: doi:10.1016/j.jconrel.2018.10.021 Reference: COREL 9504 To appear in: Journal of Controlled Release Received date: 14 May 2018 Revised date: 8 October 2018 Accepted date: 16 October 2018 Please cite this article as: Vidhi M. Shah, Duc X. Nguyen, Adel Al Fatease, Pragnesh Patel, Brianna Cote, Yeonhee Woo, Rohi Gheewala, Yvonne Pham, Man Gia Huynh, Christen Gannett, Deepa A. Rao, Adam W.G. Alani , Liposomal formulation of hypoxia activated prodrug for the treatment of ovarian cancer. Corel (2018), doi:10.1016/ j.jconrel.2018.10.021 This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.